Skip Navigation

Journal of Tropical Pediatrics 1995 41(6):364-365; doi:10.1093/tropej/41.6.364
© 1995 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Girgis, N. I.
Right arrow Articles by Farid, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Girgis, N. I.
Right arrow Articles by Farid, Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

research-article

Short Course Chemotherapy with Cefixime in Children with Multidrug-resistant Salmonella typhi Septicaemia

N. I. Girgis*,, D. R. Tribble*, Y. Sultan** and Z. Farid*

*US Naval Medical Research Unit No. 3 Cairo, Egypt
**Abbassia Fever Hospital Cairo, Egypt

Correspondence: N. I. Girgis, Research Publication Branch, U.S. Naval Medical Research Unit No. 3, PSC 452, Box 5000, Code (304A), FPO, AE 09835–0007.

Increasing prevalence of multidrug-resistant (MDR) Salmonella typhi strains in pediatric cases of typhoid fever and chemotherapy restrictions in children, such as fluoroquinolones, require ongoing clinical evaluations of different antibiotic regimens. Previously reported clinical trials with oral cefixime therapy given as a 12-day regimen (20–30 mg/kg divided twice daily) demonstrated both safety and efficacy. An open trial was undertaken to investigate a short course (8-day) regimen of oral cefixime in an Egyptian public fever hospital. Eighty children were initially enrolled with Mood culture confirmation in 60 children. Clinical cure was documented in 57 (95 per cent) with three children requiring a change in antibiotic regimen due to therapeutic failure and one child with culture-confirmed relapsed 21 days post-therapy. All S. typhi isolates were sensitive to cefixime as measured by disk diffusion. Cefixime was well-tolerated with only mild side-effects, including nausea/vomiting (8 per cent) and abdominal cramping with loose stools (6 per cent), which may have been secondary to typhoid fever. Cefixime given in a short 8-day course is safe and effective in the management of MDR typhoid fever in children.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
T. F. Ismail, H. Smits, M. O. Wasfy, J. L. Malone, M. A. Fadeel, and F. Mahoney
Evaluation of Dipstick Serologic Tests for Diagnosis of Brucellosis and Typhoid Fever in Egypt
J. Clin. Microbiol., September 1, 2002; 40(9): 3509 - 3511.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Y. Matsumoto, A. Ikemoto, Y. Wakai, F. Ikeda, S. Tawara, and K. Matsumoto
Mechanism of Therapeutic Effectiveness of Cefixime against Typhoid Fever
Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2450 - 2454.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.